New Zealand Trade Talks With U.S. Could Speed Access To Newer Drugs
This article was originally published in PharmAsia News
New Zealand is negotiating a free trade agreement with the United States that could lead to New Zealanders gaining earlier access to new and expensive drugs
You may also be interested in...
The UK’s implementation of a new national pathway for biosimilars has been pushed back from the start of 2021, with the MHRA citing “intense COVID-19 activities” as a cause of an indefinite delay in the consultation process.
Hikma has temporarily stopped the roll-out of its rival to Advair Diskus in the US after it filed an amendment to its ANDA over packaging controls.
Chad Reynolds of RMQ+ spoke to Medtech Insight about practical strategies for managing economic operators efficiently and with a view to long-term compliance.